REgenerative Stem cell therapy for STroke in Europe
Call identifier: H2020-PCH-2015-RTD
Grant agreement nº: 681044
This project has received funding from the European Community's Horizon 2020 Programme under grant agreement no. 681044.
The primary objective of the RESSTORE translational project is to provide, through a European multicentre randomised phase IIb clinical study, essential information on the therapeutic efficacy of IV delivery of allogenic adipose tissue derived MSCs (ADMSCs) in 400 stroke patients.